Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice-Reference-Cited by-同舟云学术

Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice

Published:2015-03-27 Issue:4 Volume:42 Page:369-379
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Rodrigues Gabriel Barros¹,Rocha Sura Wanessa Santos¹,Santos Laise Aline Martins dos¹,de Oliveira Wilma Helena¹,Gomes Fabiana Oliveira dos Santos¹,de França Maria Eduarda da Rocha¹,Lós Deniele Bezerra²,Peixoto Christina Alves¹

Affiliation:

1. Ultrastructure Laboratory; Institute Aggeu Magalhães - FIOCRUZ; Recife Brazil

2. Postgraduate Program in Biotechnology (RENORBIO); Federal University of Pernambuco; Pernambuco Brazil

Funder

Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE)

Centro de Pesquisas Aggeu Magalhães - Fundação Oswaldo Cruz (CPqAM/FIOCRUZ)

Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem (INBEB)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/PAPES VI)

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12369/fullpdf

Reference55 articles.

1. Review article: Current management of alcoholic liver disease;Tome;Aliment. Pharmacol. Ther.,2004

2. Alcoholic liver disease;Bruha;World J. Hepatol.,2012

3. Alcoholic liver disease: Pathogenesis and new therapeutic targets;Gao;Gastroenterology,2011

4. Innate immunity in alcoholic liver disease;Gao;Am. J. Physiol. Gastrointest. Liver Physiol.,2011

5. Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy;Orman;J. Gastroenterol. Hepatol.,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatoprotective effect of prenatal celecoxib in weaning preeclamptic rats: Role of HMGB1/MAPKs signaling;European Journal of Pharmacology;2024-09

2. Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis;Medical Hypotheses;2022-03

3. Multi-omics Analysis of Liver Infiltrating Macrophages Following Ethanol Consumption;Scientific Reports;2019-05-23

4. Current Therapeutic Strategies for Alcoholic Liver Disease;Dietary Interventions in Liver Disease;2019

5. A new diethylcarbamazine formulation (NANO-DEC) as a therapeutic tool for hepatic fibrosis;International Immunopharmacology;2018-11